Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
13 June 2016 |
Main ID: |
NCT01833221 |
Date of registration:
|
12/04/2013 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty
FacialReinn |
Scientific title:
|
Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty |
Date of first enrolment:
|
April 2013 |
Target sample size:
|
10 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT01833221 |
Study type:
|
Interventional |
Study design:
|
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Daniel Labbé, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University Hospital, Caen |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patient who were operated for a facial paralysis by the lengthening temporalis
myoplasty procedure in the University Hospital of Caen and who present signs of
contraction of the facial muscles on the plasy side after the procedure.
Exclusion Criteria:
- Patient with contraindications to the injection of lidocaine
- Patient treated with beta-blocker
- Patient on anti-coagulants
- Pathology cause of facial paralysis evolving
- Pregnant or lactating
- Patient incapacitated adult
- Patient undergoing another study at the same time
Age minimum:
6 Years
Age maximum:
70 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Facial Paresis
|
Intervention(s)
|
Drug: injection of 1% lidocaine, 2mL for facial nerve block
|
Primary Outcome(s)
|
Facial muscle contraction after nerve block
[Time Frame: 30 minutes after lidocaine injection]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|